SELLAS Life Sciences Group, Inc.
Status: Publicly traded
Direct answer
SELLAS Life Sciences Group, Inc. is publicly traded on NASDAQ under the ticker SLS.
SELLAS Life Sciences Group, Inc. operates as a late-stage biopharmaceutical entity, dedicated to advancing novel cancer immunotherapies for various cancer indications across the United States. Its primary investigational product, galinpepimut-S (GPS), is a cancer immunotherapeutic agent engineered to target Wilms tumor 1. GPS is currently in Phase III clinical trials for acute myeloid leukemia and Phase 1/2 studies...
Can you invest in SELLAS Life Sciences Group, Inc.?
Yes. SELLAS Life Sciences Group, Inc. trades publicly on NASDAQ as SLS.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for SELLAS Life Sciences Group, Inc.
Detailed equity research is provided by MarketSnap.